On January 23, DOT published a Notice of Proposed Rulemaking to amend its drug-testing program regulation, despite an order from President Trump barring federal agencies from publishing regulations in the Federal Register.
Trump's order prohibits regulations from being published unless a Trump-picked agency chief signs off. It also directed agencies to immediately withdraw any submitted regulations before they can be published.